课题基金 / 基金详情

ETEC EPIDEMIOLOGY AND VACCINE RESEARCH IN LOWER EGYPT

ETEC EPIDEMIOLOGY AND VACCINE RESEARCH IN LOWER EGYPT
下埃及的 ETEC 流行病学和疫苗研究
批准号:
2449784
负责人:
J D CLEMENS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

J D CLEMENS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Enterotoxigenic Escherichia coli (ETEC) diarrhea is hyperendemic among young Egyptian children, with a balanced distribution of toxin phenotypes from pathogenic isolates. These features make it logical to develop a field site for the evaluation of ETEC epidemiology and ETEC vaccines in Egypt. We have begun a collaborative program to develop a field site near Alexandria for the study of pediatric ETEC diarrhea, and to evaluate the safety and immunogenicity of a promising killed oral ETEC vaccine candidate in preparation for a field trial of vaccine efficacy. This program of projects has followed two pediatric cohorts, one in Abees (Alexandria governorate) and the other in Abu Homos (Beheira governorate) to determine the age-specific incidence rate of ETEC diarrhea from birth to 35 months, by toxin and colonization factor (CFA) phenotype; and to evaluate the protective relationship between titers of serum IgG antibodies to ETEC toxins and CFAs and the risk of diarrhea due to ETEC manifesting these virulence factors. During two years of follow-up of 242 children in Abees, the incidence of ETEC diarrhea was found to be .9 episodes per child-year, and 88% of isolates expressed LT-only or ST-only. Approximately one-fourth of cases were due to an ETEC that expressed a recognized CFA antigen. Among the 286 children followed for one-year in Abu Homos, the incidence of ETEC was 1.4 episodes per child-year, with 80% of isolates expressing LT-only or ST-only, and ca. 40% of isolates expressed a CFA. A randomized, placebo-controlled Phase 2 study of killed oral ETEC vaccine, administered as a two-dose regimen to 76 adults in Benha, near Cairo, demonstrated the vaccine to be well-tolerated and to induce signficant musosal immune responses to vaccine antigens. A similarly designed trial of the vaccine, administered to 110 children aged 6-12 years in the same site was recently conducted. No serious reactions were noted, but definitive analyses await unblinding of the codes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EVALUATION OF A WATER-SANITATION INTERVENTION IN EGYPT
MATERNAL CHILD HEALTH PROJECT OF ASSIUT, EGYPT
EVALUATION OF A WATER-SANITATION INTERVENTION IN EGYPT
EPIDEMIOLOGY OF TYPHOID FEVER IN INDIA
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: